Welcome to mySIMPONI® (golimumab)
This website is intended for patients who live in the UK and have been prescribed SIMPONI® (golimumab).
For information on SIMPONI® indications, please consult the Patient Information Leaflet (PIL):
- If you are prescribed SIMPONI® as a 50 mg pre-filled syringe, please consult this PIL
- If you are prescribed SIMPONI® as a 50 mg pre-filled pen, please consult this PIL
- If you are prescribed SIMPONI® as a 100 mg pre-filled pen, please consult this PIL
For members of the public, you can visit the Johnson & Johnson Innovative Medicine UK website.
To enter the website, please confirm that you are a patient prescribed SIMPONI® by ticking the box below.
The information provided on this website is not a substitute for professional medical care. If you have any concerns about your health or medicine, you should consult your healthcare specialist or general practitioner. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
Reporting side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine.
